Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zen-Zen Biotechnology develops and provides advanced cellular therapies including mesenchymal stem cells, immune cell therapies, and exosomes. The company has initiated Phase I clinical trials in collaboration with major hospitals in Taiwan targeting late-stage non-small cell lung cancer using autologous cytokine-induced killer cells combined with chemotherapy. Additional research focuses include endometrial stem cells, pulmonary fibrosis, Parkinson’s disease, wound repair, and anti-aging applications through exosome-based products. The company actively collaborates with academic institutions such as National Tsing Hua University.[1][2]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zen-Zen Biotechnology Co., Ltd..